Franklin Biotechnology Discovery Fund

Scorecard
3 / 5 Stars
Lipper
4 4 4 3 3
Zacks Investment Research
1 (Strong Buy)
Standard & Poor's
4 / 5 Stars
TheStreet.com
B+ (Buy)

Fund Holdings

Asset Allocation

% Long % Short % Net
Cash 7.81 1.94 5.87
Stocks 90.65 0.0 90.65
Bonds 0.0 0.0 0.0
Other 0.32 0.0 0.32
Foreign Bonds 0.0 0.0 0.0
Foreign Stocks 3.16 0.0 3.16
Convertible 0.0 0.0 0.0
Preferred 0.0 0.0 0.0

Updated 12.31.2013

Top 10 Holdings

Performance as of 02.28.2014

Portfolio as of 12.31.2013

Ticker YTD Return % % Net Assets
Gilead Sciences Inc GILD 8.46 9.94
Celgene Corporation CELG -5.14 9.75
Biogen Idec Inc BIIB 21.04 6.77
Amgen Inc AMGN 8.96 6.22
Medivation, Inc. MDVN 11.89 4.1
Regeneron Pharmaceuticals, Inc. REGN 23.35 3.84
Alexion Pharmaceuticals, Inc. ALXN 29.76 3.61
Incyte Corp Ltd INCY 25.91 3.03
Vertex Pharmaceuticals VRTX 9.77 2.93
Biomarin Pharmaceutical, Inc. BMRN 13.32 2.61

See Also:

Top Franklin Templeton Investments Funds